Transcenta is a clinical stage biopharmaceutical company that fully integrates antibody-based biotherapeutics discovery, research, development and manufacturing. On September 29, 2021, Transcenta was listed on the Main Board of the Stock Exchange of Hong Kong Limited with the stock code: 06628. Transcenta has established global footprint, with Headquarters and Discovery, Clinical and Translational Research Center in Suzhou, Process and Product Development Center and Manufacturing Facility in Hangzhou, and Clinical Development Centers in Beijing, Shanghai and Guangzhou in China and in Princeton, US, and External Partnering Center in Boston and Los Angeles, US. Transcenta is developing nine therapeutic antibody molecules for oncology and selected non-oncology indications including bone and kidney disorders. For more information, please visit www.transcenta.com.
View Top Employees from Transcenta| Website | http://www.transcenta.com |
| Revenue | $28.4 million |
| Funding | $105 million |
| Employees | 96 (79 on RocketReach) |
| Founded | 2019 |
| Phone | +86 571 2827 9502 |
| Technologies |
JavaScript,
HTML,
PHP
+6 more
(view full list)
|
| Industry | Biotechnology Research, Business Services General, Biopharma, Drug Discovery, Business Services, Biotechnology, Health Care, Science and Engineering |
| SIC | SIC Code 873 Companies, SIC Code 87 Companies |
| NAICS | NAICS Code 541 Companies, NAICS Code 5417 Companies, NAICS Code 54 Companies, NAICS Code 54171 Companies, NAICS Code 541714 Companies |
Looking for a particular Transcenta employee's phone or email?
Transcenta Questions
The Transcenta annual revenue was $28.4 million in 2024.
Christopher Hwang is the CTO of Transcenta.
79 people are employed at Transcenta.
Transcenta is based in Hangzhou, Zhejiang.
The NAICS codes for Transcenta are [541, 5417, 54, 54171, 541714].
The SIC codes for Transcenta are [873, 87].
Top Transcenta Employees
-
33
-
22
-
35+
-
34
-
44
-
Related Companies
